November 2021
BIU has announced a new $75 million, comprehensive program to help transform diabetes care in the region and spur innovations in treatment and prevention world-wide.
Read more »
October 2021
Combining biology with machine learning, a new treatment developed at Bar-Ilan focuses on destroying cancer cells without endangering healthy cells.
Read more »
October 18, 2020
A team at BIU has obtained approval for a clinical trial to mitigate lung injury and the need for artificial respiration & ventilator support in COVID-19 patients.
Read more »
June 2, 2020
The tunnel is equipped with an automated aerosol spray system which quickly disinfects individuals, clothes and potentially contaminated belongings.
Read more »
March 2020
[VIDEO] Dr. Baruch Barzel, Network Scientist at Bar-Ilan, talks about mitigating the spread of Coronavirus.
Read more »
March 2020
Ran Kremer, a Master’s student in electrical engineering at Bar-Ilan University, shows how the Kalman filter can accurately predict the worldwide spread of coronavirus.
Read more »
March 2020
An Israeli startup will donate around 120,000 masks made with an anti-pathogen, anti-bacterial fabric
that could help stop the spread of coronavirus.
Read more »
February 2020
Using a new technology developed by Dr. Amos Danielli, of the Alexander Kofkin Faculty of Engineering at Bar-Ilan University, saliva tests can be analyzed within 15 minutes.
Read more »
October 2019
Prof. Moshe Bar, head of the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University, has ADHD and is proud of it. “I don’t see ADHD as a disorder,” he explains. “It confers advantages. It’s nature’s way of enriching diversity, so that not everyone thinks the same way.”
Read more »
December 2018
Gavriel Friedbauer’s chesed project is fine-tuned to his family’s history, indicating deep family love and sensitivity. Gavriel was inspired by Dr. Eitan Okun’s research on Alzheimer’s disease at Bar-Ilan University.
Read more »
December 2018
BIU researchers have discovered that an enzyme normally found only in sperm cells is the same one that enables cancer cells to metastasize throughout the body, and devised a synthetic compound to disable it.
Read more »
November 2017
For children suffering from sickle-cell anemia, cancer and immune diseases such as the “bubble boy” syndrome, the prognosis is bleak: pain, severe discomfort, difficulty in pursuing a normal lifestyle, and an uncertain future.
Novel research underway in Dr. Ayal Hendel’s Genome Editing & Gene Therapy Laboratory at BIU’s Mina and Everard Goodman Faculty of Life Sciences may now offer promise and a new lease on life for countless youths.
Read more »
October 2017
With the potential of speeding cures for diseases as diverse as cancer, autism and eye disease, Bar-Ilan University Professor Rachela Popovtzer was chosen, from among dozens of research groups world-wide, to head up the European Union (EU) nTrack project, part of EU’s Horizon 2020 research program.
Read more »
August 17, 2017
Why was a nice Jewish boy from Teaneck handling SQUIDs for seven weeks this summer? Don’t worry. He wasn’t working with the decidedly non-kosher shellfish. Ari Krischer was working in Dr. Beena Kalisky’s lab at Bar-Ilan, testing superconducting quantum interference devices.
Read more »
October 2016
Internationally recognized for his pioneering research into Tourette syndrome, BIU neurophysiologist Prof. Izhar Bar-Gad has uncovered the mechanism that determines the timing of tics associated with the disorder that affects millions of children and adults, an important step toward understanding and, hopefully, also controlling the involuntary head jerking, rapid blinking, “barking” and even cursing and rib punching, which exacerbate their daily lives.
Read more »
June 2016
Since joining BIU’s School of Engineering in 2014, Dr. Amos Danielli is exploring new medical applications for the novel technology he developed, which can help shorten diagnosis time for heart patients
Read more »
April 2016
A novel study conducted by BIU scientists points to an exciting new direction in cancer research.
Read more »
August 2015
The positive impact that the BIU Medical School is now having on improving healthcare in the Galilee and strengthening medical research worldwide was recently recognized through a major grant by Israel’s Council for High Education and partnership funding by Teva Pharmaceutical Industries.
Read more »
June 2015
An important link between the Lin28 gene and Wilms Tumor has recently been identified by Dr. Achia Urbach, a senior lecturer at BIU. Wilms Tumor comes about due to the improper development of the kidney during the fetal stage, and is the most common form of kidney cancer in children.
Read more »
June 2015
In what promises to be a major breakthrough in the treatment of shingles, scientists at Bar-Ilan have been the first to recreate the dormant/active behavior of the varicella zoster virus (VZV), which causes chicken pox. Shingles, which afflicts tremendous pain on millions of adults every year, is caused by a “similar” virus.
Read more »
